Baxter restarted a second IV solutions manufacturing line at its North Carolina facility this week as part of its recovery following Hurricane Helene. The line, along with the first that restarted Oct. 28, represents 50% of the site’s total production capacity and 85% of its production of 1-liter IV solutions, according to a Nov. 14 news release from the company.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis
